ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 57 filers reported holding ALPINE IMMUNE SCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $137,400 | +11.4% | 12,000 | 0.0% | 0.01% | +9.1% |
| Q2 2023 | $123,360 | +33.2% | 12,000 | 0.0% | 0.01% | +22.2% |
| Q1 2023 | $92,640 | +5.0% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $88,200 | -48.7% | 12,000 | -50.0% | 0.01% | -10.0% |
| Q3 2022 | $172,000 | -19.6% | 24,000 | -4.5% | 0.01% | -16.7% |
| Q2 2022 | $214,000 | +25.1% | 25,120 | +103.2% | 0.01% | -29.4% |
| Q4 2021 | $171,000 | +58.3% | 12,360 | +3.0% | 0.02% | +54.5% |
| Q2 2021 | $108,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $17,640,000 | 4.25% |
| BVF INC/IL | 1,201,717 | $8,244,000 | 0.92% |
| Orbimed Advisors | 3,670,955 | $25,183,000 | 0.39% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $945,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 475,450 | $3,262,000 | 0.12% |
| Hikari Power Ltd | 122,972 | $844,000 | 0.09% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 15,000 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 35,750 | $245,000 | 0.00% |
| DRW Securities, LLC | 10,000 | $69,000 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 134,542 | $923,000 | 0.00% |